Skip to main content
All lobbying filings

B HALL STRATEGIES, LLC

B HALL STRATEGIES, LLC filed a Q3 report for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. on October 20, 2026, reporting $30,000 in lobbying income.

Lobbying for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

All filings by B HALL STRATEGIES, LLC · Everything TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • JAMES BRYANT HALL II
    Previously held: Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Pharmacy

Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.

 Bills named in this filing 1
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem